These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31239240)

  • 1. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
    Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
    Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
    Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
    Parise CA; Caggiano V
    BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer.
    Harari A; Li N; Yeh MW
    J Clin Endocrinol Metab; 2014 Jan; 99(1):133-41. PubMed ID: 24243631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival disparities among African American women with invasive bladder cancer in Florida.
    Brookfield KF; Cheung MC; Gomez C; Yang R; Nieder AM; Lee DJ; Koniaris LG
    Cancer; 2009 Sep; 115(18):4196-209. PubMed ID: 19569251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
    Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
    Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer.
    Nazemi A; Ghodoussipour S; Pearce S; Bhanvadia S; Daneshmand S
    Urol Oncol; 2019 Oct; 37(10):784-790. PubMed ID: 31076355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
    Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
    Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are There Racial or Socioeconomic Disparities in Ambulatory Outcome or Survival After Oncologic Spine Surgery for Metastatic Cancer? Results From a Medically Underserved Center.
    De la Garza Ramos R; Javed K; Ryvlin J; Gelfand Y; Murthy S; Yassari R
    Clin Orthop Relat Res; 2023 Feb; 481(2):301-307. PubMed ID: 36198109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
    Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
    J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry.
    Lara J; Brunson A; Keegan TH; Malogolowkin M; Pan CX; Yap S; deVere White R
    J Urol; 2016 Nov; 196(5):1378-1382. PubMed ID: 27208515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States.
    Seo M; Langabeer Ii JR
    J Prev Med Public Health; 2018 Sep; 51(5):242-247. PubMed ID: 30286596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?
    Morales J; Malles A; Kimble M; Rodriguez de la Vega P; Castro G; Nieder AM; Barengo NC
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540198
    [No Abstract]   [Full Text] [Related]  

  • 18. Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System.
    Kantor O; Wang ML; Bertrand K; Pierce L; Freedman RA; Chavez-MacGregor M; King TA; Mittendorf EA
    Ann Surg Oncol; 2022 Jan; 29(1):686-696. PubMed ID: 34331158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women.
    Martínez ME; Gomez SL; Tao L; Cress R; Rodriguez D; Unkart J; Schwab R; Nodora JN; Cook L; Komenaka I; Li C
    Breast Cancer Res Treat; 2017 Nov; 166(1):185-193. PubMed ID: 28698973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
    Weiner AB; Keeter MK; Manjunath A; Meeks JJ
    Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.